|
|
|
|
LEADER |
05416nam a22005175i 4500 |
001 |
978-0-387-72573-4 |
003 |
DE-He213 |
005 |
20151204181350.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387725734
|9 978-0-387-72573-4
|
024 |
7 |
|
|a 10.1007/978-0-387-72573-4
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RM1-950
|
072 |
|
7 |
|a MMG
|2 bicssc
|
072 |
|
7 |
|a MED071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615
|2 23
|
245 |
1 |
0 |
|a Neuroimmune Pharmacology
|h [electronic resource] /
|c edited by Howard E. Gendelman, Tsuneya Ikezu.
|
264 |
|
1 |
|a Boston, MA :
|b Springer US,
|c 2008.
|
300 |
|
|
|a L, 828 p. 164 illus., 40 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Immunology of the Nervous System -- Introducing Neuroimmune Pharmacology -- Innate and Adaptive Immunity in Health and Disease -- Anatomical Networks: Structure and Function of the Nervous System -- The Blood Brain Barrier -- Anterior Chamber and Retina -- Hippocampus and Spatial Memory -- Glial and Neuronal Cellular Compostion, Biology, and Physiology -- Astrocytes, Oligodendrocytes, and Schwann Cells -- Macrophages, Microglia, and Dendritic C -- Neuronal and Glial Signaling -- The Vertebrate Retina -- Lymphocytes and the Nervous System -- Stem Cells -- Neurobiology and Neural Systems -- Cytokines and Chemokines -- CNS Cell Signaling -- Nervous System Diseases and Immunity: Clinical Descriptions -- Neurodegeneration -- Multiple Sclerosis and Other Demyelinating Diseases -- Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Axonal Degeneration and Regeneration -- Guillain-Barré Syndrome -- Autoimmune Disease -- NeuroAIDS -- HTLV-I/II -- Viral Encephalitis -- Alzheimer's Disease -- Parkinson's Disease -- Amyotrophic Lateral Sclerosis -- Huntington's Disease -- Prion Diseases -- Glaucoma -- Stroke and Cerebrovascular Disease -- Neurogenesis and Brain Repair -- Familial Neurodegenerative Diseases and Single Nucleotide Polymorphisms -- The Neuroimmune System in Psychiatric Disorders -- Major Depression, Bipolar Syndromes, and Schizophrenia -- Molecular Pathogenesis for Schizophrenia and Major Depression -- Drugs of Abuse and the Immune System -- Therapeutics -- Neuropharmacology -- Neurodegenerative Diseases -- Multiple Sclerosis -- HIV-Associated Dementia -- Immunotherapy -- Alzheimer's Disease -- Parkinson's Disease and Amyotrophic Lateral Sclerosis -- Protective and Regenerative Autoimmunity in CNS Injury -- Adjuvants -- Polymer Nanomaterials -- Gene Therapy and Vaccination -- Proteomics and Genomics -- Neuroimaging.
|
520 |
|
|
|a The chapters contained in this volume show scientific relationships among historically separated fields. This allows a unique opportunity for scientists and students to gain broad knowledge in disparate fields of clinical medicine and biomedical research. Overall, the text integrates cutting-edge neuroscience, immunology, pharmacology, neurogenetics, neurogenesis, gene therapy, adjuvant therapy, proteomics, and magnetic resonance imaging. It is a rich harvest and readers will gain a perspective that has not been readily available. Exposure to such a wealth of ideas is bound to inspire readers to undertake new and productive research initiatives. In summary, this is a volume not to be put on the shelf as a reference, but to be read cover to cover by aspiring neuroscientists. Dr. Patrick L. McGeer Professor Emeritus Kinsmen Laboratory of Neurological Research, University of British Columbia This exciting new textbook, Neuroimmune Pharmacology, reflects the history and vision of the Society on NeuroImmune Pharmacology and of the Society’s official publication, the Journal of Neuroimmune Pharmacology. All three represent deliberations arising from a relatively young, interdisciplinary, and dynamic field of research, which have major translational implications for neurodegenerative, neuroinflammatory, neuropsychiatric diseases, and infections of the nervous system. They all demonstrate the synergistic value of integrating the parts: Neuroscience, Immunology, and Pharmacology. The extraordinary accomplishment of Neuroimmune Pharmacology is its comprehensive nature. It will be enthusiastically welcomed by members of the Society and will serve as the definitive resource for all students and researchers interested in various topics that are so well covered in the book. Dr. Phillip K. Peterson President, Society on NeuroImmune Pharmacology Professor, Department of Medicine, University of Minnesota.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Human physiology.
|
650 |
|
0 |
|a Immunology.
|
650 |
|
0 |
|a Neurosciences.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Cell biology.
|
650 |
1 |
4 |
|a Biomedicine.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Immunology.
|
650 |
2 |
4 |
|a Neurosciences.
|
650 |
2 |
4 |
|a Cell Biology.
|
650 |
2 |
4 |
|a Human Physiology.
|
700 |
1 |
|
|a Gendelman, Howard E.
|e editor.
|
700 |
1 |
|
|a Ikezu, Tsuneya.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387725727
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-0-387-72573-4
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SBL
|
950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|